Immunosuppression: Clinical Trials

5 trials for Immunosuppression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 active not recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Active not recruiting 5

Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Tacrolimus Pill, Tacrolimus capsule - Immunosuppression
Phase 4Active not recruitingEdward Geissler3222024-03-092026-11-05
Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
Prednisone, Azathioprine, Placebo Prednisone - Myocarditis, Heart Failure
Phase 4Active not recruitingMedical University of Warsaw1002022-12-012026-09-22
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
Pitavastatin, PCSK9 inhibitor - Dyslipidemias, Hyperlipidemias
Phase 4Active not recruitingNational Medical Research Center for Therapy and Preventive Medicine592021-10-012025-01-22
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
Reduction in antimetabolite immunosuppression - COVID-19, Immunosuppression
Phase 4Active not recruitingUniversity of California, Davis142021-09-242026-04-03
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
low dose tacrolimus in combination with everolimus, standard dose tacrolimus with mycophenolate mofetil - Renal Transplant Recipients, Elderly Patients
Phase 4Active not recruitingUniversity Medical Center Groningen3742019-07-292023-05-10

Narrower conditions

COVID-19 (1)  ·  Cardiomyopathies (1)  ·  Dyslipidemias (1)  ·  Heart Failure (1)  ·  Hyperlipidemias (1)  ·  Myocarditis (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Heart Diseases (1)  ·  Infections (1)  ·  Lipid Metabolism Disorders (1)  ·  Lung Diseases (1)  ·  Metabolic Diseases (1)  ·  Nidovirales Infections (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

Tacrolimus (2)  ·  Azathioprine (1)  ·  Everolimus (1)  ·  Mycophenolic Acid (1)  ·  Prednisone (1)  ·  pitavastatin (1)

Sponsors

Edward Geissler (1)  ·  Medical University of Warsaw (1)  ·  National Medical Research Center for Therapy and Preventive Medicine (1)  ·  University Medical Center Groningen (1)  ·  University of California, Davis (1)

Countries

Belgium (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Aiko De Vries, MD, PhD (1)  ·  Alexandra Ershova, PhD (1)  ·  Arjan Van Zuilen, MD, PhD (1)  ·  Azam Nurmohamed, Md, PhD (1)  ·  Bernhard Banas, MD (1)  ·  Dennis Hesselink, MD, PhD (1)  ·  Dirk Kuypers, MD, PhD (1)  ·  Frederike Bemelman, Md, PhD (1)  ·  Jan-Stephan Sanders, MD, PhD (1)  ·  Luuk Hilbrands, Md, PhD (1)  ·  Marcin Grabowski, Professor (1)  ·  Stefan Berger, Md, PhD (1)

Results publications

PMID 34078323, PMID 37382155, PMID 40197799, PMID 41201871

NIH funding

2023 (1)